Shareholders Equity ratio Analysis of Entrada Therapeutics Inc - Deep Dive


Shareholders Equity of TRDA
Dec-23
51.65
Good Shareholders Equity
Dec-22
84.33
Excellent Shareholders Equity
Growth
-38.75
%
Shareholders Equity Analysis of Entrada Therapeutics Inc
Shareholders Equity Ratio of TRDA drastically fell by -38.75 % this year.
Shareholders Equity Ratio with value of 97.67 was highest in Year Dec-21 in last Five Years.
Shareholders Equity Ratio with value of -95.32 was lowest in Year Dec-20 in last Five Years.
Latest Shareholders Equity Ratio with value of 51.65 is Greater than Average Shareholders Equity of 10.65 in last five years.
Other Shareholders Equity Related Info of TRDA that may interest you.
Entrada Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
TRDA15.4715.63 1.02 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Good Stability
FY - Historical Shareholders Equity of Entrada Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
Shareholders Equity51.6584.3397.67-95.32-85.09
Change-38.75 %-13.66 %202.47 %-12.03 %
FY Chart of Shareholders Equity of Entrada Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)